Clinical trial
A Randomized, Double-Blind, Placebo Controlled, Parallel-Arm Pilot Evaluation - to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough
NCT07690059 is registered in ClinicalTrials.gov with Sensory Cloud, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo Controlled, Parallel-Arm Pilot Evaluation - to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough
- Lead sponsor
- Sensory Cloud, Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 13, 2026
- Completion date
- April 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
refractory chronic cough and unexplained chronic cough